Skip to main content
Top
Published in: BMC International Health and Human Rights 1/2012

Open Access 01-12-2012 | Debate

Combating healthcare corruption and fraud with improved global health governance

Authors: Tim K Mackey, Bryan A Liang

Published in: BMC International Health and Human Rights | Issue 1/2012

Login to get access

Abstract

Corruption is a serious threat to global health outcomes, leading to financial waste and adverse health consequences. Yet, forms of corruption impacting global health are endemic worldwide in public and private sectors, and in developed and resource-poor settings alike. Allegations of misuse of funds and fraud in global health initiatives also threaten future investment. Current domestic and sectorial-level responses are fragmented and have been criticized as ineffective. In order to address this issue, we propose a global health governance framework calling for international recognition of “global health corruption” and development of a treaty protocol to combat this crucial issue.
Appendix
Available only for authorised users
Literature
1.
go back to reference Growing threat from counterfeit medicines. Bull. World Health Organ. 2010, 88: 247-248. Growing threat from counterfeit medicines. Bull. World Health Organ. 2010, 88: 247-248.
5.
go back to reference Kirigia JM, Diarra-Nama AJ: Can countries of the WHO African Region wean themselves off donor funding for health?. Bull. World Health Organ. 2008, 86: 889-92. 10.2471/BLT.08.054932. discussion 893–5CrossRefPubMedPubMedCentral Kirigia JM, Diarra-Nama AJ: Can countries of the WHO African Region wean themselves off donor funding for health?. Bull. World Health Organ. 2008, 86: 889-92. 10.2471/BLT.08.054932. discussion 893–5CrossRefPubMedPubMedCentral
7.
go back to reference Holmberg S, Rothstein B: Dying of corruption. Health Econ Policy Law. 2011, 6: 529-47. 10.1017/S174413311000023X.CrossRefPubMed Holmberg S, Rothstein B: Dying of corruption. Health Econ Policy Law. 2011, 6: 529-47. 10.1017/S174413311000023X.CrossRefPubMed
10.
go back to reference Global Corruption Report 2006. 2005, London: Transparency International, 1-378. Global Corruption Report 2006. 2005, London: Transparency International, 1-378.
11.
go back to reference Vian T: Review of corruption in the health sector: theory, methods and interventions. Health Policy Plan. 2008, 23: 83-94.CrossRefPubMed Vian T: Review of corruption in the health sector: theory, methods and interventions. Health Policy Plan. 2008, 23: 83-94.CrossRefPubMed
14.
go back to reference Garuba HA, Kohler JC, Huisman AM: Transparency in Nigeria's public pharmaceutical sector: perceptions from policy makers. Global Health. 2009, 5: 14-10.1186/1744-8603-5-14.CrossRefPubMedPubMedCentral Garuba HA, Kohler JC, Huisman AM: Transparency in Nigeria's public pharmaceutical sector: perceptions from policy makers. Global Health. 2009, 5: 14-10.1186/1744-8603-5-14.CrossRefPubMedPubMedCentral
15.
go back to reference Cohen JC, Mrazek M, Hawkins L: Tackling corruption in the pharmaceutical systems worldwide with courage and conviction. Clin Pharmacol Ther. 2007, 81: 445-449. 10.1038/sj.clpt.6100074.CrossRefPubMed Cohen JC, Mrazek M, Hawkins L: Tackling corruption in the pharmaceutical systems worldwide with courage and conviction. Clin Pharmacol Ther. 2007, 81: 445-449. 10.1038/sj.clpt.6100074.CrossRefPubMed
16.
go back to reference Liang BA: Fade to black: importation and counterfeit drugs. Am J Law Med. 2006, 32: 279-323.PubMed Liang BA: Fade to black: importation and counterfeit drugs. Am J Law Med. 2006, 32: 279-323.PubMed
20.
go back to reference Solberg KE: India's health sector responds to new corruption charges. Lancet. 2008, 371: 464-10.1016/S0140-6736(08)60220-2.CrossRefPubMed Solberg KE: India's health sector responds to new corruption charges. Lancet. 2008, 371: 464-10.1016/S0140-6736(08)60220-2.CrossRefPubMed
21.
go back to reference Cohen J: HIV/AIDS. Uganda confronts corruption, slowly. Science. 2008, 321: 522-525. 10.1126/science.321.5888.522.CrossRefPubMed Cohen J: HIV/AIDS. Uganda confronts corruption, slowly. Science. 2008, 321: 522-525. 10.1126/science.321.5888.522.CrossRefPubMed
22.
23.
go back to reference Usher AD: Defrauding of the global fund gives Sweden cold feet. Lancet. 2010, 376: 1631-10.1016/S0140-6736(10)62081-8.CrossRefPubMed Usher AD: Defrauding of the global fund gives Sweden cold feet. Lancet. 2010, 376: 1631-10.1016/S0140-6736(10)62081-8.CrossRefPubMed
27.
go back to reference Mackey T, Liang B: Off Label Promotion Reform: A Legislative Proposal Addressing Vulnerable Patient Drug Access and Limiting Inappropriate Pharmaceutical Marketing. University of Michigan J. of Law Reform. 2011, 45: 1-54. Mackey T, Liang B: Off Label Promotion Reform: A Legislative Proposal Addressing Vulnerable Patient Drug Access and Limiting Inappropriate Pharmaceutical Marketing. University of Michigan J. of Law Reform. 2011, 45: 1-54.
Metadata
Title
Combating healthcare corruption and fraud with improved global health governance
Authors
Tim K Mackey
Bryan A Liang
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC International Health and Human Rights / Issue 1/2012
Electronic ISSN: 1472-698X
DOI
https://doi.org/10.1186/1472-698X-12-23

Other articles of this Issue 1/2012

BMC International Health and Human Rights 1/2012 Go to the issue